Stanisic, Sanja, Antonio Bertolotto, Patrizia Berto, Di ProcoloPaolo, and Julia Morawski. 2019. “The Cost-Effectiveness of Alemtuzumab in the Management of Relapse-Remitting Multiple Sclerosis in Italy”. Global & Regional Health Technology Assessment 6 (1). https://doi.org/10.33393/grhta.2019.465.